Back from the brink: catastrophic antiphospholipid syndrome

Am J Med. 2015 Jun;128(6):574-7. doi: 10.1016/j.amjmed.2015.01.002. Epub 2015 Jan 14.

Authors

Tanush Gupta¹, Sahil Khera², Dhaval Kolte¹, Wilbert S Aronow³, Tarunjit Singh³, Sowmya Pinnamaneni³, John T Fallon⁴, William H Frishman¹, Alan Gass³

Affiliations

¹ Department of Medicine, New York Medical College, Valhalla.
² Division of Cardiology, Department of Medicine, New York Medical College, Valhalla. Electronic address: sahil_khera@nymc.edu.
³ Division of Cardiology, Department of Medicine, New York Medical College, Valhalla.
⁴ Department of Pathology, New York Medical College, Valhalla.

PMID: 25596523
DOI: 10.1016/j.amjmed.2015.01.002

No abstract available

MeSH terms

Adult
Anticoagulants / therapeutic use
Antiphospholipid Syndrome / complications*
Antiphospholipid Syndrome / diagnosis*
Cardiotonic Agents / therapeutic use
Cyclophosphamide / administration & dosage
Cyclophosphamide / therapeutic use
Dobutamine / therapeutic use
Extracorporeal Membrane Oxygenation
Female
Heparin / administration & dosage
Heparin / therapeutic use
Humans
Immunoglobulins, Intravenous / administration & dosage
Immunoglobulins, Intravenous / therapeutic use
Immunosuppressive Agents / therapeutic use
Methylprednisolone / administration & dosage
Methylprednisolone / therapeutic use
Mitral Valve Insufficiency / diagnosis
Mitral Valve Insufficiency / pathology
Plasmapheresis
Shock, Cardiogenic / diagnosis*
Warfarin / therapeutic use

Substances

Anticoagulants
Cardiotonic Agents
Immunoglobulins, Intravenous
Immunosuppressive Agents
Dobutamine
Warfarin
Cyclophosphamide
Heparin
Methylprednisolone